PERMIXON 160 mg Hard Capsule
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PERMIXON 160 mg Hard Capsule, covering 2014-01-15 to 2014-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) [Phase 4]